Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease

NCT03978156 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03978156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03978156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Terminated
Start date
July 26, 2019
Completion date
January 1, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease